Squarepoint Ops »

Kailera Therapeutics shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Kailera Therapeutics shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Kailera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kailera Therapeutics held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kailera Therapeutics by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2026-06-30 $993k 45k 22.03

More positions owned by Squarepoint Ops

Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Advanced Micro Devices (AMD)
Ishares Tr Russell 2000 Etf (IWM)
Micron Technology (MU)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Apple (AAPL)
Applied Materials (AMAT)
Tesla Motors (TSLA)
Intel Corporation (INTC)
Ishares Tr 20 Yr Tr Bd Etf (TLT)

View all positions for Squarepoint Ops

Top funds holding Kailera Therapeutics

Bain Capital Investors
Bain Capital Life Sciences Investors
Rtw Investments
Canada Pension Plan Investment Board
Atlas Venture Life Science Advisors
FMR
BlackRock
Citadel Advisors
Adage Capital Partners GP
Wellington Management Company
Royalty Pharma Sub-Manager
Siren
Vanguard Capital Management
Vanguard Portfolio Management
Geode Capital Management

View all funds holding Kailera Therapeutics